A study for a 54 year old woman who takes Butrans, Sertraline, Baclofen - from FDA reports

692 females aged 54 (±5) who take the same drugs are studied. This is a personalized study for a 54 year old female patient who has Pain Management, Anxiety, Muscle Spasm. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.

On Feb, 19, 2019

692 females aged 54 (±5) who take Butrans, Sertraline, Baclofen are studied.

Number of reports submitted per year:

Butrans, Sertraline, Baclofen for a 54-year old woman.

Information of the patient in this study:

  • Age: 54
  • Gender: female
  • Conditions: Pain Management, Anxiety, Muscle Spasm
  • Drugs taken:
    • Butrans (buprenorphine)
    • Sertraline (sertraline hydrochloride)
    • Baclofen (baclofen)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Mouth Dry Aggravated(worse dry mouth): 0 (0% of females aged 54 (±5) who take the drugs)
  • Palpitations Aggravated(feelings or sensations that your heart is pounding or racing- aggravated): 17 (2.46% of females aged 54 (±5) who take the drugs)
  • Sweating Increased(excess sweating): 0 (0% of females aged 54 (±5) who take the drugs)
  • Dry Eyes(lack of adequate tears): 4 (0.58% of females aged 54 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  1. Diarrhea
  2. Dizziness
  3. Hypopnea
  4. Application site inflammation
  5. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  6. Breathing difficulty
  7. Nausea (feeling of having an urge to vomit)
  8. Application site rash
  9. Pulse pressure increased
  10. Confusion
1 - 6 months:
  1. Hyperaesthesia
  2. Nausea (feeling of having an urge to vomit)
  3. Application site rash
  4. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  5. Oedema peripheral (superficial swelling)
  6. Swelling
  7. Piloerection (goose bumps)
  8. Urinary retention (the inability to completely or partially empty the bladder)
  9. Cystitis interstitial (unknown cause characterized by bladder pain)
  10. Urticaria (rash of round, red welts on the skin that itch intensely)
6 - 12 months:
  1. Injection site mass
  2. Application site pruritus (application site severe itching of the skin)
  3. Swelling
  4. Injection site pruritus (severe itching at injection site)
  5. Joint pain
  6. Cystitis interstitial (unknown cause characterized by bladder pain)
  7. Injection site pain
  8. Oedema peripheral (superficial swelling)
  9. Osteoporosis (bones weak and more likely to break)
  10. Injection site swelling
1 - 2 years:
  1. Weight decreased
  2. Cardiac failure congestive
  3. Lip swelling
  4. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
  5. Taste - impaired
  6. Oedema (fluid collection in tissue)
  7. High blood cholesterol
2 - 5 years:
  1. Interstitial nephritis (inflammation of the kidney)
  2. Acute kidney failure
  3. Chronic kidney disease
5 - 10 years:
10+ years:
not specified:
  1. Fall
  2. Nausea (feeling of having an urge to vomit)
  3. Weakness
  4. Fatigue (feeling of tiredness)
  5. Headache (pain in head)
  6. Dizziness
  7. Urinary tract infection
  8. Diarrhea
  9. Gait disturbance
  10. Nausea and vomiting

Top conditions involved for these people *:

  1. Gait Disturbance : 78 people, 11.27%
  2. High Blood Pressure : 30 people, 4.34%
  3. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 27 people, 3.90%
  4. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 25 people, 3.61%
  5. Osteoporosis (bones weak and more likely to break): 24 people, 3.47%
  6. High Blood Cholesterol : 23 people, 3.32%
  7. Sleep Disorder : 21 people, 3.03%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 18 people, 2.60%
  9. Asthma : 18 people, 2.60%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 18 people, 2.60%

Top co-used drugs for these people *:

  1. Ampyra (137 people, 19.80%)
  2. Neurontin (93 people, 13.44%)
  3. Tecfidera (83 people, 11.99%)
  4. Gilenya (80 people, 11.56%)
  5. Avonex (71 people, 10.26%)
  6. Tysabri (67 people, 9.68%)
  7. Vitamin D (59 people, 8.53%)
  8. Lyrica (57 people, 8.24%)
  9. Synthroid (57 people, 8.24%)
  10. Vitamin D3 (57 people, 8.24%)

* Some reports may have incomplete information.

You are not alone:

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Related publications that referenced our studies

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...


Thank you!